Burman WJ - Search Results

1

The hunt for the elusive surrogate marker of sterilizing activity in tuberculosis treatment.

Burman WJ. Burman WJ. Am J Respir Crit Care Med. 2003 May 15;167(10):1299-301. doi: 10.1164/rccm.2302003. Am J Respir Crit Care Med. 2003. PMID: 12738594 No abstract available.

2

Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis.

Burman W, Benator D, Vernon A, Khan A, Jones B, Silva C, Lahart C, Weis S, King B, Mangura B, Weiner M, El-Sadr W; Tuberculosis Trials Consortium. Burman W, et al. Am J Respir Crit Care Med. 2006 Feb 1;173(3):350-6. doi: 10.1164/rccm.200503-417OC. Epub 2005 Aug 18. Am J Respir Crit Care Med. 2006. PMID: 16109981 Clinical Trial.

3

Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy.

Burman WJ, Jones BE. Burman WJ, et al. Am J Respir Crit Care Med. 2001 Jul 1;164(1):7-12. doi: 10.1164/ajrccm.164.1.2101133. Am J Respir Crit Care Med. 2001. PMID: 11435232 Review. No abstract available.

4

Comparison testing of current (PPD-S1) and proposed (PPD-S2) reference tuberculin standards.

Villarino ME, Brennan MJ, Nolan CM, Catanzaro A, Lundergan LL, Bock NN, Jones CL, Wang YC, Burman WJ. Villarino ME, et al. Among authors: burman wj. Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1167-71. doi: 10.1164/ajrccm.161.4.9906050. Am J Respir Crit Care Med. 2000. PMID: 10764307 Clinical Trial.

5

Hepatotoxicity from rifampin plus pyrazinamide: lessons for policymakers and messages for care providers.

Burman WJ, Reves RR. Burman WJ, et al. Am J Respir Crit Care Med. 2001 Oct 1;164(7):1112-3. doi: 10.1164/ajrccm.164.7.2109052. Am J Respir Crit Care Med. 2001. PMID: 11673194 No abstract available.

6

DNA fingerprinting with two probes decreases clustering of Mycobacterium tuberculosis.

Burman WJ, Reves RR, Hawkes AP, Rietmeijer CA, Yang Z, el-Hajj H, Bates JH, Cave MD. Burman WJ, et al. Am J Respir Crit Care Med. 1997 Mar;155(3):1140-6. doi: 10.1164/ajrccm.155.3.9117000. Am J Respir Crit Care Med. 1997. PMID: 9117000

7

The incidence of false-positive cultures for Mycobacterium tuberculosis.

Burman WJ, Stone BL, Reves RR, Wilson ML, Yang Z, El-Hajj H, Bates JH, Cave MD. Burman WJ, et al. Am J Respir Crit Care Med. 1997 Jan;155(1):321-6. doi: 10.1164/ajrccm.155.1.9001331. Am J Respir Crit Care Med. 1997. PMID: 9001331

8

Sorting out icebergs, mirages, and clinical tuberculosis during active case finding.

Reves RR, Burman WJ. Reves RR, et al. Among authors: burman wj. Am J Respir Crit Care Med. 2009 Dec 15;180(12):1167-9. doi: 10.1164/rccm.200909-1332ED. Am J Respir Crit Care Med. 2009. PMID: 19949239 No abstract available.

9

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.

Burman WJ, Goldberg S, Johnson JL, Muzanye G, Engle M, Mosher AW, Choudhri S, Daley CL, Munsiff SS, Zhao Z, Vernon A, Chaisson RE. Burman WJ, et al. Am J Respir Crit Care Med. 2006 Aug 1;174(3):331-8. doi: 10.1164/rccm.200603-360OC. Epub 2006 May 4. Am J Respir Crit Care Med. 2006. PMID: 16675781 Clinical Trial.

10

Recurrent tuberculosis in the United States and Canada: relapse or reinfection?

Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ, Metchock B, Khan A, Burman WJ; Tuberculosis Trials Consortium. Jasmer RM, et al. Among authors: burman wj. Am J Respir Crit Care Med. 2004 Dec 15;170(12):1360-6. doi: 10.1164/rccm.200408-1081OC. Epub 2004 Oct 11. Am J Respir Crit Care Med. 2004. PMID: 15477492 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results